GGrantIndex
Sort

64,565 grants matching drug discovery

Targeting the Hedgehog Pathway in Pediatric Brain Tumors

$503,843
Tom Curran · St. Jude Children'S Research Hospital · P01 · FY2012 · CA

Personalized therapy for AATD-associated liver disease via IPS modeling

$503,793
Andrew A Wilson · Boston University Medical Campus · R01 · FY2015 · DK

Gonococci: Genetics of Resistance to PMN Proteins

$503,711
William Maurice Shafer · Emory University · R01 · FY2023 · AI

Prevention of Esophageal Cancer with Berries

$503,687
Gary D Stoner · Ohio State University · R01 · FY2007 · CA

Targeted Degradation of EGFR and HER2 in NSCLC

$503,685
Yuesheng Zhang · Virginia Commonwealth University · R01 · FY2024 · CA

Drug Discovery for Fatty Acid Synthase in Oncology

$503,641
Jeffrey W Smith · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2012 · CA

Development and Application of Selective Covalent Cdk7 Inhibitors

$503,599
Nathanael Schiander Gray · Dana-Farber Cancer Inst · R01 · FY2015 · CA

Small Molecule Drug Discovery for CLN3 and CLN6 Disease

$503,579
Paul Trippier · University Of Nebraska Medical Center · R01 · FY2025 · HD

Discovering Antimicrobial Drugs from Symbiotic Actinobacteria from Terrestrial

$503,572
Cameron Robert Currie · University Of Wisconsin-Madison · U19 · FY2014 · AI

Develop BCL-xL proteolysis targeting chimeras as safer and better senolytics

$503,572
Guangrong Zheng · University Of Florida · R01 · FY2022 · AG

Epigenetics and disease: the role of DNA methylation in schizophrenia susceptibil

$503,548
Roel A Ophoff · University Of California Los Angeles · R01 · FY2012 · DA

Developing Novel Protein-based GABA Sensor Modules Using PLP-dependent GabR Regulators

$503,535
Dali Liu · Loyola University Of Chicago · R15 · FY2025 · GM

Anticoagulant thrombins in vitro and in vivo

$503,523
Washington University · R01 · FY2003 · HL

Small Molecule Drug Discovery for CLN3 and CLN6 Disease

$503,500
Paul Trippier · University Of Nebraska Medical Center · R01 · FY2024 · HD

NCI Experimental Therapeutics-Clinical Trials Network with Phase 1 Emphasis

$503,482
Ramesh Ramanathan · Mayo Clinic Rochester · UM1 · FY2015 · CA

Computational Approaches for RNA StructureFunction Determination

$503,448
Bruce Shapiro · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA

DBM Anti-Proliferative Lead Small Molecules for Polycystic Kidney Disease

$503,386
Erik Mills Schwiebert · Discoverybiomed, Inc. · R44 · FY2014 · DK

N-type Calcium Channels in Nocipeptive Neurons

$503,338
Diane Lipscombe · Brown University · R01 · FY2015 · NS

Characterizing and Targeting BAX- and BAK-Dependent Cell Death in Cancer

$503,337
Emily H Cheng · Sloan-Kettering Inst Can Research · R01 · FY2022 · CA

Characterizing and Targeting BAX- and BAK-Dependent Cell Death in Cancer

$503,337
Emily H Cheng · Sloan-Kettering Inst Can Research · R01 · FY2023 · CA

Project 1

$503,275
Duygu Tosun-Turgut · Northern California Institute/Res/Edu · U19 · FY2025 · AG

SYSTEM FOR AUTOMATED NONINVASIVE MONITORING OF MOUSE SLEEP AND BEHAVIOR

$503,214
Michael E Lhamon · Signal Solutions, Llc · R44 · FY2015 · NS

AutoDock Software Development and Maintenance

$503,210
Arthur J. Olson · Scripps Research Institute, The · R01 · FY2009 · GM

Chemical Synthesis of Chiral Bioactive Molecules

$503,137
Sarah Elizabeth Reisman · California Institute Of Technology · R35 · FY2016 · GM

Regulation of Cell Migration in Development

$503,096
Denise J. Montell · Johns Hopkins University · R01 · FY2012 · GM